Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis

2021/02/14 by Takeshi Kuwada, Masahiro Shiokawa, Yuzo Kodama +26 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Cell Adhesion Molecules Research #Systemic Lupus Erythematosus Research

paper · pdf · doi:10.1053/j.gastro.2021.02.019

Citations

• Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
• Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

Cited by

• B cells in inflammatory bowel disease
• The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. [europepmc]
• Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis. [europepmc]
• Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA Pathway. [europepmc]
• Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. [europepmc]
• Measurement of Serum IgG Anti-Integrin αvβ6 Autoantibodies Is a Promising Tool in the Diagnosis of Ulcerative Colitis. [europepmc]
• Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology. [europepmc]
• Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis. [europepmc]
• Remodeling of colon plasma cell repertoire within ulcerative colitis patients. [europepmc]
• Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis. [europepmc]
• Microscopic Colitis: Pathogenesis and Diagnosis. [europepmc]
• Biomarkers in IBD: What to Utilize for the Diagnosis? [europepmc]
• Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis. [europepmc]
• Clinical Validity of Anti-Proteinase 3 Antibodies in Patients with Inflammatory Bowel Disease: A Short Meta-Analysis. [europepmc]
• Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. [europepmc]
• Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis. [europepmc]
• Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond. [europepmc]
• Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers. [europepmc]
• Mini review of first-in-human integrin αvβ6 PET tracers. [europepmc]
• Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity. [europepmc]
• Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis. [europepmc]
• Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study. [europepmc]
• Probiotic nanocomposite materials with excellent resistance, inflammatory targeting, and multiple efficacies for enhanced treatment of colitis in mice. [europepmc]
• Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis. [europepmc]
• Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease. [europepmc]
• Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseases. [europepmc]